ezetimibe has been researched along with camptothecin in 4 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (camptothecin) | Trials (camptothecin) | Recent Studies (post-2010) (camptothecin) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 13,002 | 2,229 | 5,391 |
Protein | Taxonomy | ezetimibe (IC50) | camptothecin (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 0.05 | |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 7.4 | |
DNA topoisomerase 1 | Homo sapiens (human) | 1.9799 | |
Somatostatin receptor type 1 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 2 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 4 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 3 | Homo sapiens (human) | 0.0022 | |
Somatostatin receptor type 5 | Homo sapiens (human) | 0.0022 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.97 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.05 | |
Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 9 | Homo sapiens (human) | 0.05 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.05 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Daidoji, T; Hu, M; Kulkarni, KH; Tang, L; Wang, JR; Wang, SW; Yin, T; Yokota, H | 1 |
Cai, H; Chen, S; Hotz, K; La Placa, DB; Nguyen, N; Peterkin, V; Stevens, JC; Tukey, RH; Yang, YS | 1 |
4 other study(ies) available for ezetimibe and camptothecin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities.
Topics: Animals; Anticholesteremic Agents; Apigenin; Azetidines; Bile; Camptothecin; Enzyme Inhibitors; Ezetimibe; Flavonoids; Genistein; Glucuronic Acid; Glucuronosyltransferase; Indomethacin; Intestinal Absorption; Intestinal Mucosa; Irinotecan; Isoflavones; Liver; Male; Microsomes; Microsomes, Liver; Protein Isoforms; Rats; Rats, Gunn; Rats, Wistar; Recombinant Proteins; Testosterone; Up-Regulation | 2009 |
A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation.
Topics: Alleles; Animals; Anticholesteremic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Azetidines; Biocatalysis; Camptothecin; Dimethyl Sulfoxide; Enzyme Induction; Ezetimibe; Gene Expression; Glucuronic Acid; Glucuronosyltransferase; Humans; Irinotecan; Kinetics; Liver; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microsomes, Liver; Models, Animal; Naloxone; Pharmaceutical Preparations; Phenobarbital; UDP-Glucuronosyltransferase 1A9 | 2010 |